Piper Sandler Maintains Overweight on Incyte, Raises Price Target to $130
Incyte Corporation
Incyte Corporation INCY | 0.00 |
Piper Sandler analyst Allison Bratzel maintains Incyte (NASDAQ:
INCY) with a Overweight and raises the price target from $110 to $130.